Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 24, 2014
83 Pages - SKU: BMI5332216
Countries covered: Zimbabwe

Zimbabwe Pharmaceuticals and Healthcare Report Q4 2014

BMI View: Zimbabwe's poor economic outlook, in addition to the government announcing budget cuts tohealthcare, means that we do not expect any meaningful interest from pharmaceutical companies in themedium-to-long term. The already dire situation, in which the health service is heavily reliant on donations,lacks skilled workers and essential medicines, and the fact that the vast majority of the healthcare budget isnot even disbursed, leads us to hold a very bleak outlook for the healthcare market in the country.

Headline Expenditure Projections

Pharmaceuticals: USD233mn in 2013 to USD251mn in 2014; +7.5% in US dollar terms. Forecastremains in line with last quarter's projections.



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Uzbekistan Q4 2014BMI View: We expect Uzbekistan's healthcare spending to continue outpacing the country's economicgrowth, creating opportunities for most health ...
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - United Arab Emirates Q4 2014BMI View: The UAE continues to appeal to businesses thanks to its growing economy, which willincreasingly ...
Pharmaceuticals and Healthcare Report - South Africa Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - South Africa Q4 2014BMI View: South Africa's tepid economic growth, depreciating currency and current account deficit willlimit the market potential ...
Pharmaceuticals and Healthcare Report - Serbia Q4 2014 by Business Monitor International
Pharmaceuticals and Healthcare Report - Serbia Q4 2014BMI View: In July, Serbia's National Health Insurance Fund (RFZO) cut medicine prices by around 50%through a new ...
See all reports like this >>

More Zimbabwe Prescription Drugs reports

Pharmaceuticals and Healthcare Report - Zimbabwe Q3 2014 by Business Monitor International
Zimbabwe Pharmaceuticals and Healthcare Report Q3 2014BMI View: Zimbabwe's pharmaceutical industry suffers significantly from the country's frail economy andongoing political instability, with neither expected to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!